Liver Metastases Treatment in Turkey

What are Liver Metastases?

Liver metastases are the dissemination of tumor cells from other body parts to the liver. This happens when the tumor cells journey through the blood or lymphatic vessels into the liver. These metastases are not primary cancers. They are secondary because they arose from another organ before their transfer to the liver.

What is the Importance of Timely Treatment?

Prevents Further Spread

Early intervention can usually prevent further spread of the cancer from the liver to the rest of the body or from one site within the liver to another, thus making treatment more difficult.

Improves Prognosis
Early treatment increases the chances of a good prognosis as it helps shrink or control tumors to prolong survival and improve the quality of life.

Maximizes Treatment Effectiveness
Early diagnosis is associated with much better efficacy of chemotherapy, targeted therapy, or surgery because, at that point, the disease is amenable to intervention.

Prevents Complications
It can also help improve any organ dysfunction or jaundice or pain symptoms that had developed owing to untreated liver metastases.

Better Response to Surgery
Early detection of metastases, which have spread to the liver exclusively, could make them amenable to surgical excision of the liver portion involved, thereby offering a chance for cure or long-term control.

What are the Common Symptoms of Liver Metastases?

• Abdominal Pain or Discomfort
• Jaundice
• Unexplained Weight Loss
• Fatigue and Weakness
• Nausea and Vomiting

Causes and Risk Factors of Liver Metastases

Causes

• Spread from Primary Cancer
• Advanced Cancer Stage

Risk Factors

• Advanced Stage of Primary Cancer
• Type of Primary Cancer
• Liver Diseases
• Genetic Factors
• Gender and Hormone
• Immunocompromised State
• Lifestyle Factors

Latest Research and Technologies in the Treatment of Liver Metastases in Turkey

Personalised therapies such as KRAS and BRAF inhibitors also manage colorectal liver metastases, progressing to changing in liver metastases treatment years later. The developments in immunotherapy, particularly with checkpoint inhibitors, have also investigated how well they do in metastasised liver cancer. Transarterial chemoembolisation (TACE) and transarterial radioembolisation (TARE) deliver attached chemotherapy or radiation directly into the lesion, thus minimising damage to healthy tissue. Minimally invasive approaches for inoperable metastases are liver-directed ablation techniques using microwave and radiofrequency ablation (RFA). Robot-assisted liver surgery provides very accurate removal of a tumor with a very rapid recovery time. 3D-printed liver models facilitate surgical planning, rendering better resection outcomes. Innovations in liquid biopsy allow tumor mutations to be monitored in real time for optimal treatment adaptations.

Liver Metastases Prevention Tip:

• Early detection and screening programs ought to be offered to those with a high risk of developing liver metastases, that is, patients with a known history of previous cancers like colorectal, breast, or lung cancer, to help catch tumours before they metastasise to the liver.
• Healthy living habits such as eating a balanced diet, exercising regularly, not smoking, and avoiding excess alcohol consumption can all lower the chances of developing cancers likely to metastasise to the liver.
• Vaccination against hepatitis B and hepatitis C may lower the chance of developing liver cancer, which represents one of the sources of liver metastases.
• Controlling risk factors for primary cancers like obesity, diabetes, and pre-existing liver disorders such as cirrhosis can minimise the risk of cancers where the secondary spread is to the liver.
• Administering treatment as soon as possible to contain primary cancer prevents its spread into the liver. The follow-up after therapy of any primary cancer is primordial for an early diagnosis of metastasis.